Literature DB >> 23609337

Growth hormone in health and disease: Biological markers of tissue-specific effects of GH therapy.

Alan D Rogol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23609337     DOI： 10.1038/nrendo.2013.80

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  7 in total

1.  Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis.

Authors:  Ruth Sanchez-Ortiga; Anne Klibanski; Nicholas A Tritos
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

2.  Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy.

Authors:  J N Roemmich; M G Huerta; S M Sundaresan; A D Rogol
Journal:  Metabolism       Date:  2001-05       Impact factor: 8.694

3.  The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients.

Authors:  J Gibney; J D Wallace; T Spinks; L Schnorr; A Ranicar; R C Cuneo; S Lockhart; K G Burnand; F Salomon; P H Sonksen; D Russell-Jones
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

4.  Overall and cause-specific mortality in GH-deficient adults on GH replacement.

Authors:  Rolf C Gaillard; Anders F Mattsson; Ann-Charlotte Akerblad; Bengt-Åke Bengtsson; José Cara; Ulla Feldt-Rasmussen; Maria Koltowska-Häggström; John P Monson; Bernhard Saller; Patrick Wilton; Roger Abs
Journal:  Eur J Endocrinol       Date:  2012-03-28       Impact factor: 6.664

5.  Protein markers predict body composition during growth hormone treatment in short prepubertal children.

Authors:  Ralph Decker; Björn Andersson; Andreas F M Nierop; Ingvar Bosaeus; Jovanna Dahlgren; Kerstin Albertsson-Wikland; Gunnel Hellgren
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-11       Impact factor: 3.478

6.  Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children.

Authors:  Björn Andersson; Gunnel Hellgren; Andreas F M Nierop; Ze'ev Hochberg; Kerstin Albertsson-Wikland
Journal:  Proteome Sci       Date:  2009-11-02       Impact factor: 2.480

7.  Fifteen years of GH replacement improves body composition and cardiovascular risk factors.

Authors:  Mariam Elbornsson; Galina Götherström; Ingvar Bosæus; Bengt-Åke Bengtsson; Gudmundur Johannsson; Johan Svensson
Journal:  Eur J Endocrinol       Date:  2013-04-15       Impact factor: 6.664
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.